Extended spectrum β-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae

Indian Journal of Medical Research

Volumn 116, Issue OCT., 2002, Pages 145-149

  Khurana, Sumeeta ^a   Taneja, Neelam ^a   Sharma, Meera ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cephalosporins; Enterobacteriaceae; ESBL; Urinary tract

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; MONOBACTAM; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CITROBACTER; CONTROLLED STUDY; DEMOGRAPHY; DIFFUSION; DRUG HYDROLYSIS; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PROTEUS; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT FAILURE; URINARY TRACT; URINARY TRACT INFECTION;

BETA-LACTAMASES; CEPHALOSPORINS; ENTEROBACTERIACEAE; FEMALE; HUMANS; MALE; URINARY TRACT;

EID: 0036820414     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24 (Suppl 1): S19-45.
2. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 39 : 1211-33.
3. Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35 : 164-9.
4. Bush K. New beta-lactamases in Gram-negative bacteria: Diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001; 32 : 1085-9.
5. Sussman M. Urinary tract infections. In: Collier L, Editor-in-chief, Balows A, Sussman M, Gen Editor. Topley & Wilson's Microbiology and Microbial Infections, Vol. 3, Hausler WJ Jr, Sussman M, editors. Bacterial infections, 9th ed. London: Arnold, 1998 p. 601-21.
6. Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J Clin Microbiol 1994; 32 : 691-6.
7. Sanders CC, Thomson KS, Bradford PA. Problems with detection of β-lactam resistance among nonfastidious Gram-negative bacilli. Infect Dis Clin North Am 1993; 7 : 411-24.
8. Chanal S, Sirot D, Romaszko JP, Bret L, Sirot J. Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother 1996; 38 : 127-32.
9. Jacoby GA, Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol, 1996; 34: 908-11.
10. Lu PYF, Gur D, Hall LMC, Livermore DM. Survey of the prevalence of β-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30 : 429-47.
11. Paterson DL, Yu VL. Extended-spectrum beta-lactamases: A call for improved detection and control. Clin Infect Dis 1999; 29: 1419-22.
12. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32 (Suppl 2) : S94-103.
13. Barnett BJ, Stephens DS. Urinary tract infections: An overview. Am J Med Sci 1997; 314: 245-9.
14. Emery CL, Weymouth LA. Detection and clinical significance of extended spectrum β-lactamases in a clinical tertiary-care medical center. J Clin Microbiol 1997; 35 : 2061-7.
15. Jones RN, Kugler KC, Pfaller MA, Winokur PL. Characteristics of pathogens causing urinary tract infections in hospitals in North America: Results from the SENTRY antimicrobial surveillance program, 1997 SENTRY Surveillance Group. Diagn Microbiol Infect Dis 1999; 35 : 55-63.
16. Coudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: Seek and you may find. J Clin Microbiol, 1997; 35: 2593-7.
17. Revathi G. Detection of extended spectrum beta lactamase using E-test ESBL strip. Indian J Med Microbiol 1997; 15 : 69-71.
18. Abigail S, Mathai E, Jesudason MV, John TJ. Ceftazidime resistance among Klebsiella pneumoniae in south India. Indian J Med Res 1995; 102 : 53-5.
19. Hansotia JB, Agarwal V. Pathak AA, Saoji AM. Extended spetrum β-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. India J Med Res 1997; 105 : 158-61.
20. Ananthakrishna AN, Kanungo R, Kumar A, Badrinath S. Detection of extended-spectrum β-lactamase producers among surgical wound infections and burns patients in JIPMER. Indian J Med Microbiol 2000; 18: 160-5.
21. Subha A, Ananthan S. Extended spectrum beta lactamase mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 2002; 20: 92-5.
22. Collee JG, Miles RS, Wan B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie & McCartney Practical Medical Microbiology, 14th ed. Edinburgh: Churchill Livingstone, 1996 p. 131-50.
23. Stokes EJ, Ridgway GL. Clinical Bacteriology: Antibacterial Drugs, 5th ed. London: Edward Arnold; 1980 p. 205-19.
24. Quinn JP. Clinical significance of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13 : (Suppl 1) : S39-42.
25. Jones RN, Winokur PL, Pfaller MA, Doern GV, Barrett T. Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American Hospitals: Results from the SENTRY Antimicrobial Surveillance Programme (1997). Clin Microbiol Infect 1999; 5 : 478-87.
26. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983 : 11 : 315-7.
27. Paterson DL, Ko W, Gottberg AV, Mohapatra S, Casellos JM, Mulazimoglu L, et al. In vitro susceptibility and clinical outcome of bacteremia due to extended spectrum beta lactamase (ESBL) producing, Klebsiella pneumoniae. Clin Infect Dis 1998; 27 : 956.
28. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409-24.